NEW YORK (Reuters Health) - Nearly a quarter of the new drugs approved in Canada eventually get a serious safety warning, or have to be pulled from the market for safety reasons, according to a new study. And for medications that get the fast-track "priority review" by the country's health regulator, the chance that a serious safety concern will surface is as high as a third, said Dr. Joel Lexchin, whose analysis was published in the Archives of Internal Medicine. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment